Bingham Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$888K Sell
965
-37
-4% -$37.5K 0.7% 38
2025
Q4
$1.08M Buy
+1,002
New +$958K 0.93% 29
2025
Q2
$778K Buy
998
+8
+0.8% +$6.22K 0.74% 34
2025
Q1
$818K Sell
990
-79
-7% -$65.7K 0.85% 33
2024
Q4
$825K Buy
+1,069
New +$885K 0.88% 33

Other funds holding LLY

Bingham Private Wealth's LLY Position: Q1 2026 in Review

Bingham Private Wealth reduced its Eli Lilly (LLY) stake by 3.7% in Q1 2026, selling an estimated $37.5K and leaving 965 shares worth $888K. The position accounts for 0.7% of the portfolio, ranked #38.

Bingham Private Wealth first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.08M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bingham Private Wealth held 965 shares of Eli Lilly worth $888K as of Q1 2026.
  • Bingham Private Wealth sold 37 Eli Lilly shares in Q1 2026, an estimated $37.5K.
  • Eli Lilly made up 0.7% of Bingham Private Wealth's portfolio in Q1 2026, its #38 holding.
  • Bingham Private Wealth first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
  • Bingham Private Wealth's Eli Lilly position peaked at $1.08M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bingham Private Wealth's 13F filing for Q1 2026, filed 7 May 2026.